Limitations of ECG Voltage Criteria for Ventricular Hypertrophy

Introduction to Ventricular Hypertrophy Diagnosis

The American College of Cardiology and Circulation journal suggest that standard ECG voltage criteria for ventricular hypertrophy are unreliable in patients with altered ventricular depolarization patterns, such as those with Left Bundle Branch Block (LBBB), Wolff-Parkinson-White (WPW) syndrome, hyperkalemia, and certain drug effects 1, 2

The presence of LBBB alters QRS morphology and voltage patterns, making it impossible to distinguish between LBBB and left ventricular hypertrophy (LVH) using standard voltage criteria, with a high prevalence of anatomic LVH in patients with LBBB (up to 90% in autopsy series) 1, 2
In patients with LBBB, the diagnosis of LVH should generally not be attempted, except in highly specific circumstances where QRS duration exceeds approximately 155 ms, left atrial abnormality is present, and precordial voltage criteria are met, with reasonable specificity but low sensitivity 1, 2, 3
Hyperkalemia progressively widens the QRS complex and increases voltage amplitude, creating false-positive voltage criteria, with elevated potassium levels slowing phase 0 of the cardiac action potential and widening the QRS complex 1, 2, 3
The American College of Cardiology recommends that echocardiography be used when ventricular hypertrophy assessment is clinically important in patients with these conditions, and that LVH/RVH should not be reported based on voltage criteria when any of these confounding conditions are present 1, 4

The American Heart Association and Circulation journal suggest that the limitation of ECG voltage criteria in patients with LBBB, WPW, hyperkalemia, and certain drug effects should be explicitly documented, and that alternative diagnostic methods such as echocardiography should be used when necessary 1, 2, 3